1'752 companies found
Bioeq AG
Zug · Since 2016
The core activity of Bioeq AG is the development, manufacture and marketing of pharmaceutical products, particularly in the field of medicinal products. The company provides services such as quality control, regulatory affairs, supply chain management and logistics to support the manufacture and distribution of medicinal products.
BiognoSYS AG
Schlieren · Since 2008
The core activity of Biognosys is the development and provision of technologies and services in the field of proteomics, particularly in the areas of large-scale proteomics, biomarker discovery and analysis. The company offers software, kits and contract research services to support customers in life science research and drug development.
BioGntx Global R&D GmbH
Zug · Since 2024
The core activity of BioGntx is the research and development of plant-based substances for medical applications in humans and animals. The company focuses on the research and development of plant-based solutions for unmet medical needs and uses modern, advanced and animal-free research methods.
BIOGRUND International AG
Steinhausen · Since 2017
The company Biogrund develops and produces solutions for the manufacture of solid dosage forms, particularly for the pharmaceutical, nutraceutical and cosmetic industries. The core activities include the development and production of: film coatings, tablet coatings, colorants, sugar coatings, capsule fillings, clean label solutions, excipients, moisture protection solutions, enteric coating solutions, solutions for replacing unwanted additives, capsule coatings, and CBD and hemp products. The company also offers services such as reformulation, customer-specific solutions, technical support and training.
BioInitials AG
Biel-Benken Bl · Since 2019
BioInitials AG develops non-invasive medical devices and a monitoring platform that analyze saliva biomarkers to assess health status, disease risk factors and disease progression. Biomarker data is combined with other inputs and evaluated using artificial intelligence; project work has included sensor units measuring saliva pH, glucose and impedance.
Biokema S.A.
Bussigny · Since 1959
The core activity of Biokema SA is the development, manufacture and marketing of pharmaceuticals and nutritional supplements for animals, particularly for pets and livestock. The company offers a wide range of products, including anti-parasitic agents, anti-infective agents, immunology products, behavioral medications, gynecology products, anti-inflammatory agents, gastro-enterology products, dermatology products and nutritional supplements. Biokema SA focuses on the health and well-being of animals and works closely with veterinarians and animal owners to offer its products and services.
Bionoltra SA
Petit-Lancy · Since 2008
The core activity of BIONOLTRA SA is the development, manufacture and marketing of medical devices and products for orthopedics and urology, particularly for the treatment of osteoarthritis and other diseases affecting the musculoskeletal system and urology.
BioNTech Switzerland GmbH
Basel · Since 2023
BioSwiss Pharmaceutical SA
Petit-Lancy · Since 2015
BioSwiss Pharmaceutical SA is a pharmaceutical company that manufactures and distributes prescription medicines and medical devices, with a focus on supplying markets that have limited access to treatments. The company commercializes products across multiple therapeutic areas (including anti-infectives, cardiology and oncology) and provides regulatory, supply-chain and licensing services in collaboration with compliant manufacturing partners.
Biotech Concepts GmbH
Zurich · Since 2005
Biotech Concepts GmbH conducts antibiotic research and develops biotechnological production processes. It provides consulting and project management for biotech and pharmaceutical projects, process development (including biocatalysis and fermentation), technology transfer, training and SOP writing, supports API production such as cephalosporins and 7‑ACA, and offers a low‑budget programmable lab/pilot automation system called ARMin.
Biotest (Schweiz) AG
Rupperswil · Since 1989
The core activity of Biotest is the development, production and distribution of biological medicines, particularly in the fields of haematology, clinical immunology and intensive care medicine. The company covers the entire process and value chain, from research and development to the collection of blood plasma in its own collection centres and the production of plasma proteins and quality assurance.
BioVersys AG
Basel · Since 2008
The core activity of Bioversys AG is the development and manufacture of pharmaceuticals, particularly in the field of antibiotic research and the development of therapeutics for various diseases. The company is engaged in the research and development of small molecules, peptides and therapeutic polymers and has experts in the fields of medicinal chemistry, CMC (Chemistry, Manufacturing, Control) and biotechnology on its team.
Bluestone Pharma GmbH
Baar · Since 2013
The core activity of Bluestone Pharma is the development, manufacture and marketing of medical probiotics, in particular oral probiotics, used to treat and prevent various health conditions. The company offers turnkey solutions and private label options to customers and focuses on delivering scientifically proven health benefits through unique probiotic strains in areas with unmet needs.
Blue Wave Therapeutics GmbH
Allschwil · Since 2021
The core activity of Blue Wave Therapeutics GmbH is the development of targeted radionuclide therapies for the treatment of solid tumors.
Boehringer Ingelheim (Schweiz) GmbH
Basel · Since 1957
Botavie SA
Geneva · Since 2000
Botavie SA offers plant-based dietary supplements and health products formulated according to the Unani tradition and markets them online under the BOTAVIE and IRELIA brands.
BridgeBio International GmbH
Zug · Since 2024
BridgeBio International GmbH is a biopharmaceutical company that develops medicines for genetic conditions and manages a pipeline of investigational candidates and approved therapies. The organization uses a hub‑and‑spoke model, partners with academic institutions, and conducts clinical research and trials.
Bristol-Myers Squibb SA
Steinhausen · Since 2002
Bristol-Myers Squibb SA is a global biopharmaceutical company that discovers, develops and delivers medicines for serious diseases. It conducts research and development, runs clinical trials and commercializes treatments in areas such as oncology, HIV and cardiovascular disease.
B SQUARED Sàrl
Neuchâtel · Since 2023
The core activity of B Squared SARL is to provide services to the life sciences industry, particularly in the areas of: bioprocess development and optimization, process modeling and software training, outsourcing and supply chain solutions, and consulting and support for the development and implementation of cell and gene therapies. The company supports customers in the development and implementation of innovative therapies and offers comprehensive services in the areas of research and development, manufacturing, quality assurance and operations.
B'SYS GmbH
Witterswil · Since 2009
The core activity of B'SYS GmbH is to provide services as a Contract Research Organization (CRO) in the field of Ion Channel Discovery for pharmaceutical companies. In particular, the company offers rapid screening services for new substances on ion channel drug targets, including safety services, discovery services, serum shift assays, action potential assays, ion channel trafficking assays, cardiac panel and cardiovascular toxicity tests.
How the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register